Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.05
Delayed Data
As of Jul 31
 -0.06 / -2.84%
Today’s Change
1.83
Today|||52-Week Range
5.48
-57.29%
Year-to-Date

Today’s Trading

Previous close2.11
Today’s open2.10
Day’s range2.01 - 2.10
Volume1,700,925
Average volume (3 months)1,540,329
Market cap$191.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-18.25%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
EARSAuris Medical Holdin...-0.04-0.78%
CUTRCutera Inc+0.16+1.07%
AXGNAxoGen Inc-0.05-1.44%
DRADDigirad Corp+0.17+4.05%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 20, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts